THNR Stock Price Prediction

The radar chart shows that buying Amplify Weight Loss Drug & Treatment ETF (THNR) stock in January has the highest probability of a positive return (100.00%), while March has the lowest probability (0.00%).

THNR's stock price fell by -11.22% in 2024,increased by 11.46% in 2025, and went down by 0.04%in 2026.

No bullish technical signals identified.

No bearish technical signals identified.

THNR has 0 buy signals and 0 sell signals now. Overall the technical rating for THNR is Neutral. Note that market conditions change all the time. In addition to technical ratings, keep an eye on the Valuation Level of THNR

Amplify Weight Loss Drug & Treatment ETF's overall moving average trend leans more bullish as of March 04 2026, with 0 negative signals and 4 positive signal.

The price prediction chart for Amplify Weight Loss Drug & Treatment ETF (THNR) stock, as of Invalid Date, forecasts a %% change over the next month, based on its high correlation with stock patterns. The similarity between their price movements over the analyzed periods is %. The right panel lists other stocks with similar price patterns. This prediction is updated every week.

In , Amplify Weight Loss Drug & Treatment ETF's value is forecasted to reach an average price of $NaN. The price is predicted to fluctuate between a low of $NaN and a high of $NaN.

In , Amplify Weight Loss Drug & Treatment ETF's value is forecasted to reach an average price of $NaN. The price is predicted to fluctuate between a low of $NaN and a high of $NaN.